202 related articles for article (PubMed ID: 22304703)
21. Alpinetin/hydroxypropyl-β-cyclodextrin host-guest system: preparation, characterization, inclusion mode, solubilization and stability.
Ma SX; Chen W; Yang XD; Zhang N; Wang SJ; Liu L; Yang LJ
J Pharm Biomed Anal; 2012; 67-68():193-200. PubMed ID: 22633603
[TBL] [Abstract][Full Text] [Related]
22. Preparation, physicochemical characteristics and bioavailability studies of an atorvastatin hydroxypropyl-beta-cyclodextrin complex.
Lv HX; Zhang ZH; Hui-Jiang ; Waddad AY; Zhou JP
Pharmazie; 2012 Jan; 67(1):46-53. PubMed ID: 22393830
[TBL] [Abstract][Full Text] [Related]
23. Characterization of an inclusion complex of ethyl benzoate with hydroxypropyl-β-cyclodextrin.
Yuan C; Lu Z; Jin Z
Food Chem; 2014; 152():140-5. PubMed ID: 24444918
[TBL] [Abstract][Full Text] [Related]
24. Effect of PVP K30 and/or L-arginine on stability constant of etoricoxib-HPbetaCD inclusion complex: preparation and characterization of etoricoxib-HPbetaCD binary system.
Shah M; Karekar P; Sancheti P; Vyas V; Pore Y
Drug Dev Ind Pharm; 2009 Jan; 35(1):118-29. PubMed ID: 18979307
[TBL] [Abstract][Full Text] [Related]
25. Effect of hydrophilic polymers on isradipine complexation with hydroxypropyl β-cyclodextrin.
Mummidi V; Jayanthi V
Drug Dev Ind Pharm; 2013 Jul; 39(7):970-7. PubMed ID: 22612875
[TBL] [Abstract][Full Text] [Related]
26. Application of a ternary HP-β-CD-complex approach to improve the dissolution performance of a poorly soluble weak acid under biorelevant conditions.
Zoeller T; Dressman JB; Klein S
Int J Pharm; 2012 Jul; 430(1-2):176-83. PubMed ID: 22531855
[TBL] [Abstract][Full Text] [Related]
27. Drug product development and pharmacological evaluation of a sparingly soluble novel camptothecin analog for peroral administration.
Nekkanti V; Karatgi P; Paruchuri S; Pillai R
Drug Deliv; 2011 May; 18(4):294-303. PubMed ID: 21214430
[TBL] [Abstract][Full Text] [Related]
28. Improvement of water solubility and in vitro dissolution rate of aceclofenac by complexation with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Ranpise NS; Kulkarni NS; Mair PD; Ranade AN
Pharm Dev Technol; 2010; 15(1):64-70. PubMed ID: 19505225
[TBL] [Abstract][Full Text] [Related]
29. Inclusion of Paracetamol into β-cyclodextrin nanocavities in solution and in the solid state.
El-Kemary M; Sobhy S; El-Daly S; Abdel-Shafi A
Spectrochim Acta A Mol Biomol Spectrosc; 2011 Sep; 79(5):1904-8. PubMed ID: 21703916
[TBL] [Abstract][Full Text] [Related]
30. Fosinopril-cyclodextrin inclusion complexes: phase solubility and physicochemical analysis.
Sbârcea L; Udrescu L; Drăgan L; Trandafirescu C; Szabadai Z; Bojiţă M
Pharmazie; 2011 Aug; 66(8):584-9. PubMed ID: 21901980
[TBL] [Abstract][Full Text] [Related]
31. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
Dhumal RS; Shimpi SL; Paradkar AR
Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
[TBL] [Abstract][Full Text] [Related]
32. Preparation and evaluation of itraconazole dihydrochloride for the solubility and dissolution rate enhancement.
Tao T; Zhao Y; Wu J; Zhou B
Int J Pharm; 2009 Feb; 367(1-2):109-14. PubMed ID: 18930795
[TBL] [Abstract][Full Text] [Related]
33. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique.
Maghsoodi M; Sadeghpoor F
Drug Dev Ind Pharm; 2010 Aug; 36(8):917-25. PubMed ID: 20180658
[TBL] [Abstract][Full Text] [Related]
34. Improving the solubility of ampelopsin by solid dispersions and inclusion complexes.
Ruan LP; Yu BY; Fu GM; Zhu DN
J Pharm Biomed Anal; 2005 Jul; 38(3):457-64. PubMed ID: 15925247
[TBL] [Abstract][Full Text] [Related]
35. Molecular simulation of hydroxypropyl-beta-cyclodextrin with hydrophobic selective Cox-II chemopreventive agent using host-guest phenomena.
Sinha VR; Nanda A; Chadha R; Goel H
Acta Pol Pharm; 2011; 68(4):585-92. PubMed ID: 21796941
[TBL] [Abstract][Full Text] [Related]
36. Effect of hydroxypropyl-beta-cyclodextrin on the solubility, stability and in-vitro release of ciprofloxacin for ocular drug delivery.
Bozkir A; Denli ZF; Basaran B
Acta Pol Pharm; 2012; 69(4):719-24. PubMed ID: 22876616
[TBL] [Abstract][Full Text] [Related]
37. Polymer-free and polyvinylpirrolidone-based electrospun solid dosage forms for drug dissolution enhancement.
Vigh T; Horváthová T; Balogh A; Sóti PL; Drávavölgyi G; Nagy ZK; Marosi G
Eur J Pharm Sci; 2013 Jul; 49(4):595-602. PubMed ID: 23684933
[TBL] [Abstract][Full Text] [Related]
38. 2-hydroxypropyl-beta-cyclodextrin increases aqueous solubility and photostability of all-trans-retinoic acid.
Lin HS; Chean CS; Ng YY; Chan SY; Ho PC
J Clin Pharm Ther; 2000 Aug; 25(4):265-9. PubMed ID: 10971776
[TBL] [Abstract][Full Text] [Related]
39. Compare and contrast the effects of surfactants (PluronicF-127 and CremophorEL) and sugars (β-cyclodextrin and inulin) on properties of spray dried and crystallised lysozyme.
Haj-Ahmad RR; Elkordy AA; Chaw CS; Moore A
Eur J Pharm Sci; 2013 Jul; 49(4):519-34. PubMed ID: 23712374
[TBL] [Abstract][Full Text] [Related]
40. Development of carvedilol-cyclodextrin inclusion complexes using fluid-bed granulation: a novel solid-state complexation alternative with technological advantages.
Alonso EC; Riccomini K; Silva LA; Galter D; Lima EM; Durig T; Taveira SF; Martins FT; Cunha-Filho MS; Marreto RN
J Pharm Pharmacol; 2016 Oct; 68(10):1299-309. PubMed ID: 27465985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
